Medicare Advantage and Prescription Drug Program: Final Marketing Provisions CFR 422.111(a)(3) and 423.128(a)(3) (CMS-10260)

ICR 202304-0938-021

OMB: 0938-1051

Federal Form Document

Forms and Documents

Document Name	Status
Attachment_C_Comments_and_Response_to_Federal_Register_Notice_2020_30 da.._ (005).docx Supplementary Document	2020-08-07
CMS-10260 Supporting_Statement A.docx Supporting Statement A	2023-04-28
Attachment_B_2021_ANOC_EOC_Crosswalk_03122020_CLEAN_with_no_issue_numbers_03162020.docx Supplementary Document	2020-04-03
Attachment_C_Comments_and_Response_to_Federal_Register_Notice_2020_03162020.docx Supplementary Document	2020-04-03

IC Document Collections

IC ID	Document Title	Status
229287	Marketing Materials	Modified
186438	Annual Notice of Change (ANOC) and Evidence of Coverage (EOC) Instruction	Modified